VAC VERAFLO
Device
KCI USA, Inc
Total Payments
$3.2M
Transactions
6,989
Doctors
3,345
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $388,656 | 543 | 371 |
| 2019 | $1.1M | 2,060 | 1,265 |
| 2018 | $741,090 | 1,538 | 583 |
| 2017 | $1.0M | 2,848 | 1,556 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.1M | 261 | 32.4% |
| Consulting Fee | $711,351 | 315 | 21.9% |
| Travel and Lodging | $623,099 | 1,911 | 19.2% |
| Food and Beverage | $290,576 | 4,351 | 8.9% |
| Unspecified | $246,610 | 19 | 7.6% |
| Grant | $155,500 | 7 | 4.8% |
| Education | $126,780 | 111 | 3.9% |
| Honoraria | $32,536 | 11 | 1.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $7,650 | 1 | 0.2% |
| Gift | $200.00 | 2 | 0.0% |
Payments by Type
General
$3.0M
6,970 transactions
Research
$246,610
19 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Retrospective and Prospective Analyses of Real World Evidence to Compare Use of KCI and 3M Products vs. Alternative Treatment Protocols on Various Wounds | KCI USA, Inc. | $105,902 | 0 |
| NPWT and INPWT-Mediated Modulation of Lymphatic Vessels in Diabetic Wound Healing - A Possible Novel Mechanism of Action and Novel Indications fo NPWT | KCI USA, Inc | $35,000 | 0 |
| Incisional negative pressure wound therapy for preoperatively irradiated lower extremity soft tissue sarcoma wounds. A prospective, randomized pilot trial. | KCI USA, Inc | $18,000 | 0 |
| AHS.2011.ULTA.04 A Prospective, Randomized, Evaluation of the Effectiveness of V.A.C. Ulta Negative Pressure Wound Therapy System with VAC. VeraFlo Dressing System in Operatively Debrided Wounds | KCI USA, Inc | $17,109 | 0 |
| Prospective Evaluation of Wound Management Using Vacuum Assisted Instillation Therapy in Emergent Contaminated Abdominal Surgeries | KCI USA, Inc | $16,628 | 0 |
| NPWT and INPWT-Mediated Modulation of Lymphatic Vessels in Diabetic Wound Healing: A Possible Novel Mechanism of Action and Novel Indication for NPWT | KCI USA, Inc. | $15,000 | 0 |
| AHS.2011.ULTA.04 A Prospective, Randomized, Evaluation of the Effectiveness of VAC Ulta Negative Pressure Wound Therapy System with VAC VeraFlo Dressing System in Operatively Debrided Wounds | KCI USA, Inc | $12,596 | 0 |
| A Prospective, Randomized, Multi-Center Trial Evaluating the Effectiveness of the V.A.C.Ulta Therapy System with V.A.C. VeraFlo Dressing in Operatively Debrided Wounds | KCI USA, Inc | $11,125 | 0 |
| Negative pressure wound therapy in post-operative incision management | KCI USA, Inc | $10,750 | 0 |
| A Prospective, Randomized, Evaluation of the Effectiveness of VAC. Ulta Negative Pressure Wound Therapy System with VAC. VeraFlo Dressing System in Operatively Debrided Wounds | KCI USA, Inc | $4,500 | 0 |
Top Doctors Receiving Payments for VAC VERAFLO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Francisco, CA | $554,544 | 99 |
| , DPM | Foot & Ankle Surgery | Washington, DC | $443,345 | 384 |
| , M.D | Plastic Surgery | Peoria, AZ | $189,406 | 244 |
| , D.O | Surgery | Las Vegas, NV | $174,465 | 290 |
| , M.D | Plastic Surgery | Newport Beach, CA | $122,583 | 99 |
| , M.D | Surgery | Cleveland, OH | $112,916 | 134 |
| , MD | Surgical Critical Care | Saint Louis, MO | $104,757 | 141 |
| , D.O | Plastic Surgery | Boca Raton, FL | $96,749 | 96 |
| , MD | Surgical Critical Care | Los Angeles, CA | $67,949 | 25 |
| , MD | Trauma Surgery | Tyler, TX | $67,293 | 95 |
| , MD | Orthopaedic Surgery | New York, NY | $50,393 | 56 |
| , MD | Surgery | Crystal Lake, IL | $48,284 | 93 |
| , MD | Orthopaedic Surgery | San Antonio, TX | $47,118 | 110 |
| , MD | Surgery | Tallahassee, FL | $44,077 | 58 |
| , DPM | Podiatrist | Newark, OH | $40,640 | 35 |
| , MD | Vascular Surgery | New York, NY | $36,469 | 19 |
| , MD FACS | Surgery | Opelousas, LA | $35,351 | 83 |
| , MD | Surgery | Vancouver, WA | $35,033 | 14 |
| , MD | Plastic Surgery | Allentown, PA | $32,380 | 28 |
| , DO | Surgery | Columbia, MO | $28,469 | 25 |
| , M.D | Plastic Surgery | Annapolis, MD | $26,377 | 84 |
| , MD | Orthopaedic Surgery | Stanford, CA | $25,426 | 20 |
| , DPM, CEO | Foot & Ankle Surgery | Poway, CA | $23,756 | 61 |
| Christopher Attinger | Plastic and Reconstructive Surgery | Washington, DC | $21,129 | 13 |
| , MD | Plastic Surgery | South Miami, FL | $19,598 | 10 |
Ad
Manufacturing Companies
- KCI USA, Inc $2.9M
- KCI USA, Inc. $388,656
Product Information
- Type Device
- Total Payments $3.2M
- Total Doctors 3,345
- Transactions 6,989
About VAC VERAFLO
VAC VERAFLO is a device associated with $3.2M in payments to 3,345 healthcare providers, recorded across 6,989 transactions in the CMS Open Payments database. The primary manufacturer is KCI USA, Inc.
Payment data is available from 2017 to 2020. In 2020, $388,656 was paid across 543 transactions to 371 doctors.
The most common payment nature for VAC VERAFLO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.1M, 32.4% of total).
VAC VERAFLO is associated with 10 research studies, including "Retrospective and Prospective Analyses of Real World Evidence to Compare Use of KCI and 3M Products vs. Alternative Treatment Protocols on Various Wounds" ($105,902).